Alpha1-Proteinase Inhibitor
460502
Approved mab completed
Quick answer
Alpha1-Proteinase Inhibitor for Alpha 1-Antitrypsin Deficiency is a Approved program (mab) at Takeda with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Takeda
- Indication
- Alpha 1-Antitrypsin Deficiency
- Phase
- Approved
- Modality
- mab
- Status
- completed